EUVIMEDEUVIMED entdecken
Crossref

Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways

Yannan Hou, Qinhan Li iD, Tong-You Wade Wei iD, Xiaoke Lin, Jieyu Guo iD, Ping Yuan iD, Hui Shen iD, Ya Gao iD, Qi Pan, Chen Xu iD, Valentina Biasin iD, Yongbo Li und 18 weitere

Circulation · 14.07.2026 · 154 (2) · 117-135

DOI: 10.1161/circulationaha.124.073606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 14.07.2026. Verfasst von Yannan Hou und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Department of Rheumatology, Zhongshan Hospital Immunotherapy Translat…. Hauptthemen laut MEDLINE: Basic-Leucine Zipper Transcription Factors, Hypoxia, Receptor, Transforming Growth Factor-beta Type II, Hypertension, Pulmonary. Die Arbeit nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Vascular remodeling is a central characteristic of pulmonary hypertension (PH), yet the precise mechanisms underlying this process remain poorly understood. METHODS: The coimmunoprecipitation assay was used to explore prolyl hydroxylase that modifies BACH1 (BTB and CNC homology 1). Cultured pulmonary artery smooth muscle cells, rodent models with PH, specimens from patients with idiopathic pulmonary arterial hypertension, and single-nucleus RNA sequencing were used to study the role of BACH1 in the regulation of PH and the underlying mechanisms. RESULTS: In this study, we found that the transcription factor BACH1 was upregulated in lung tissues and pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension and animals with experimental PH. Under normoxia, the prolyl hydroxylation of BACH1, mediated by PHD (prolyl hydroxylase) 2, facilitated BACH1 degradation by VHL (von Hippel–Lindau) protein. Hypoxic exposure decreased this prolyl hydroxylation with subsequent increased BACH1 protein stability. The deficiency or overexpression of BACH1 in smooth muscle cells in mice alleviated or exacerbated pulmonary vascular remodeling and hypoxia-induced PH. Hypoxia triggered the accumulation of BACH1 and its recruitment to the promoter region of TGFBR2 (transforming growth factor β receptor type II) in smooth muscle cells. This recruitment activated TGFBR2 transcription, thereby promoting vascular remodeling by upregulating SMAD (suppressor of mothers against decapentaplegic) signaling and extracellular matrix deposition. Decreased TGFBR2 expression or inhibited kinase activity significantly attenuated the BACH1-induced extracellular matrix genes. Furthermore, the BACH1-enhanced PH development was blunted by a TGFBR2 kinase inhibitor. CONCLUSIONS: Our study illustrates that BACH1 is prolyl-hydroxylated in an oxygen/PHD-dependent manner, affecting its stability through VHL. BACH1 is crucial for hypoxia-induced PH by activating TGFBR2/SMAD in smooth muscle cells. Thus, BACH1 inhibition may be a potential therapeutic strategy for PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic-Leucine Zipper Transcription FactorsHypoxiaReceptor, Transforming Growth Factor-beta Type IIHypertension, PulmonaryAnimalsHumansUp-RegulationSignal TransductionMiceMaleVascular RemodelingMice, Inbred C57BLRatsMyocytes, Smooth MuscleCells, CulturedMuscle, Smooth, VascularHypoxia-Inducible Factor-Proline DioxygenasesMice, Knockout

Stichwörter der Autor:innen

BACH1PHD2TGFBR2extracellular matrixpulmonary hypertension

Substanzen

Basic-Leucine Zipper Transcription FactorsReceptor, Transforming Growth Factor-beta Type IIBACH1 protein, humanBach1 protein, mouseHypoxia-Inducible Factor-Proline Dioxygenases

Autor:innen und Institutionen

  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Department of Rheumatology, Zhongshan Hospital Immunotherapy Translational Research Center (Y. Hou, Q. Li, X.L., J.G., Q.P., Y.L., Y. He, J…
  • Division of Cardiology, Department of Medicine, University of California, San Diego (T.-Y.W.W., J.Y.-J.S.).
  • Department of Cardio-Pulmonary Circulation, Innovation and Incubation Center, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, China (P.Y.).
  • Department of Cardiology, Affiliated Hospital of Yangzhou University, Yangzhou University, Institute of Cardiovascular Disease, Yangzhou Key Laboratory of Innovation Frontiers in Cardiovascular Disease, China (H.S., Y.G…
  • Department of Pathology (C.X.), Fudan University, Shanghai, China.
  • Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation (V.B., E.O.).

ORCID-Profile: Qinhan Li, Tong-You Wade Wei, Jieyu Guo, Ping Yuan, Hui Shen, Ya Gao, Chen Xu, Valentina Biasin, Jian Wu, Liliang Li, Lefeng Qu, Qianqian Liang, Elena Osto, John Y-J Shyy, Xinhong Wang, Dan Meng

Zitieren

APA

Hou, Y., Li, Q., Wei, T. W., Lin, X., Guo, J., Yuan, P., Shen, H., Gao, Y., Pan, Q., Xu, C., Biasin, V., Li, Y., He, Y., Wu, J., Li, L., Jin, J., Wei, X., Lin, J., Ma, S., …, & Meng, D. (2026). Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways. Circulation, 154(2), 117-135. https://doi.org/10.1161/circulationaha.124.073606

Vancouver

Hou Y, Li Q, Wei TW, Lin X, Guo J, Yuan P, et al. Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways. Circulation. 2026;154(2):117-135. doi:10.1161/circulationaha.124.073606

BibTeX
@article{Hou2026,
  author = {Hou, Yannan and Li, Qinhan and Wei, Tong-You Wade and Lin, Xiaoke and Guo, Jieyu and Yuan, Ping and Shen, Hui and Gao, Ya and Pan, Qi and Xu, Chen and Biasin, Valentina and Li, Yongbo and He, Yunquan and Wu, Jian and Li, Liliang and Jin, Jiayu and Wei, Xiangxiang and Lin, Jiayi and Ma, Siyu and Jiang, Nan and Ma, Jinghua and Zhi, Xiuling and Jiang, Qingjun and Qu, Lefeng and Liang, Qianqian and Jiang, Lindi and Osto, Elena and Shyy, John Y-J and Wang, Xinhong and Meng, Dan},
  title = {Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {2},
  pages = {117--135},
  doi = {10.1161/circulationaha.124.073606}
}
Kostenlos starten →